# Great Southern Bancorp, Inc.: financial statements, quarterly

GSBC · Nasdaq · CIK 854560 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gsbc.md) · [Financials](/companies/gsbc/financials.md) · [Filings](/companies/gsbc/filings.md) · [Insiders](/companies/gsbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gsbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [28.5](/filings/0001410578-23-002223.md) | [31.3 d](/filings/0001410578-24-000178.md) | [32.6](/filings/0001410578-24-000572.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.3](/filings/0001410578-24-001769.md) | [3.2 d](/filings/0001104659-26-024659.md) | [3.2](/filings/0001410578-25-001089.md) | [3.9](/filings/0001410578-25-001607.md) | [3.6](/filings/0001104659-25-107609.md) | [3.0 d](/filings/0001104659-26-024659.md) | [4.3](/filings/0001104659-26-057039.md) | [4.5](/filings/0001104659-26-092625.md) | [4.3](/filings/0001104659-25-107609.md) | [3.2 d](/filings/0001104659-26-024659.md) | [4.0](/filings/0001104659-26-057039.md) | [2.8](/filings/0001104659-26-092625.md) |
| Net income | $m | [15.9](/filings/0001410578-24-001769.md) | [13.1 d](/filings/0001104659-26-024659.md) | [13.4](/filings/0001410578-25-001089.md) | [17.0](/filings/0001410578-25-001607.md) | [16.5](/filings/0001104659-25-107609.md) | [14.9 d](/filings/0001104659-26-024659.md) | [17.2](/filings/0001104659-26-057039.md) | [19.8](/filings/0001104659-26-092625.md) | [17.8](/filings/0001104659-25-107609.md) | [16.3 d](/filings/0001104659-26-024659.md) | [17.5](/filings/0001104659-26-057039.md) | [15.8](/filings/0001104659-26-092625.md) |
| Diluted EPS | $ per share | [1.33](/filings/0001410578-24-001769.md) | not reported | [1.13](/filings/0001410578-25-001089.md) | [1.45](/filings/0001410578-25-001607.md) | [1.41](/filings/0001104659-25-107609.md) | not reported | [1.47](/filings/0001104659-26-057039.md) | [1.72](/filings/0001104659-26-092625.md) | [1.56](/filings/0001104659-25-107609.md) | not reported | [1.58](/filings/0001104659-26-057039.md) | [1.43](/filings/0001104659-26-092625.md) |
| Basic EPS | $ per share | [1.33](/filings/0001410578-24-001769.md) | not reported | [1.14](/filings/0001410578-25-001089.md) | [1.46](/filings/0001410578-25-001607.md) | [1.41](/filings/0001104659-25-107609.md) | not reported | [1.47](/filings/0001104659-26-057039.md) | [1.73](/filings/0001104659-26-092625.md) | [1.57](/filings/0001104659-25-107609.md) | not reported | [1.59](/filings/0001104659-26-057039.md) | [1.45](/filings/0001104659-26-092625.md) |

- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [182](/filings/0001410578-23-002223.md) | [211](/filings/0001410578-25-000294.md) | [171](/filings/0001410578-24-000572.md) | [186](/filings/0001410578-24-001169.md) | [208](/filings/0001410578-24-001769.md) | [196](/filings/0001104659-26-024659.md) | [217](/filings/0001410578-25-001089.md) | [246](/filings/0001410578-25-001607.md) | [196](/filings/0001104659-25-107609.md) | [190](/filings/0001104659-26-092625.md) | [187](/filings/0001104659-26-057039.md) | [180](/filings/0001104659-26-092625.md) |
| Total assets | $m | [5,748](/filings/0001410578-23-002223.md) | [5,812](/filings/0001410578-25-000294.md) | [5,777](/filings/0001410578-24-000572.md) | [5,959](/filings/0001410578-24-001169.md) | [6,037](/filings/0001410578-24-001769.md) | [5,982](/filings/0001104659-26-024659.md) | [5,994](/filings/0001410578-25-001089.md) | [5,855](/filings/0001410578-25-001607.md) | [5,738](/filings/0001104659-25-107609.md) | [5,599](/filings/0001104659-26-092625.md) | [5,687](/filings/0001104659-26-057039.md) | [5,523](/filings/0001104659-26-092625.md) |
| Total liabilities | $m | [5,216](/filings/0001410578-23-002223.md) | [5,241](/filings/0001410578-25-000294.md) | [5,212](/filings/0001410578-24-000572.md) | [5,390](/filings/0001410578-24-001169.md) | [5,424](/filings/0001410578-24-001769.md) | [5,382](/filings/0001104659-26-024659.md) | [5,381](/filings/0001410578-25-001089.md) | [5,232](/filings/0001410578-25-001607.md) | [5,105](/filings/0001104659-25-107609.md) | [4,962](/filings/0001104659-26-092625.md) | [5,054](/filings/0001104659-26-057039.md) | [4,881](/filings/0001104659-26-092625.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [532](/filings/0001410578-23-002223.md) | [572](/filings/0001410578-25-000294.md) | [565](/filings/0001410578-24-000572.md) | [569](/filings/0001410578-24-001169.md) | [612](/filings/0001410578-24-001769.md) | [600](/filings/0001104659-26-024659.md) | [613](/filings/0001410578-25-001089.md) | [622](/filings/0001410578-25-001607.md) | [633](/filings/0001104659-25-107609.md) | [636](/filings/0001104659-26-092625.md) | [634](/filings/0001104659-26-057039.md) | [642](/filings/0001104659-26-092625.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.8 d](/filings/0001410578-24-001769.md) | [13.8 d](/filings/0001104659-26-024659.md) | [(26.9)](/filings/0001410578-25-001089.md) | [43.5 d](/filings/0001410578-25-001607.md) | [17.7 d](/filings/0001104659-25-107609.md) | [9.8 d](/filings/0001104659-26-024659.md) | [15.0](/filings/0001104659-26-057039.md) | [39.3 d](/filings/0001104659-26-092625.md) | [5.6 d](/filings/0001104659-25-107609.md) | [21.6 d](/filings/0001104659-26-024659.md) | [21.2](/filings/0001104659-26-057039.md) | [6.1 d](/filings/0001104659-26-092625.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001410578-24-001769.md) | [1.1 d](/filings/0001104659-26-024659.md) | [0.8](/filings/0001410578-25-001089.md) | [1.5 d](/filings/0001410578-25-001607.md) | [1.2 d](/filings/0001104659-25-107609.md) | [1.4 d](/filings/0001104659-26-024659.md) | [1.9](/filings/0001104659-26-057039.md) | [4.4 d](/filings/0001104659-26-092625.md) | [1.7 d](/filings/0001104659-25-107609.md) | [3.4 d](/filings/0001104659-26-024659.md) | [1.3](/filings/0001104659-26-057039.md) | [3.4 d](/filings/0001104659-26-092625.md) |
| Dividends paid | $m | [4.8 d](/filings/0001410578-24-001769.md) | [4.7 d](/filings/0001104659-26-024659.md) | [4.7](/filings/0001410578-25-001089.md) | [4.7 d](/filings/0001410578-25-001607.md) | [4.6 d](/filings/0001104659-25-107609.md) | [4.7 d](/filings/0001104659-26-024659.md) | [4.7](/filings/0001104659-26-057039.md) | [4.6 d](/filings/0001104659-26-092625.md) | [4.6 d](/filings/0001104659-25-107609.md) | [4.8 d](/filings/0001104659-26-024659.md) | [4.8](/filings/0001104659-26-057039.md) | [4.7 d](/filings/0001104659-26-092625.md) |
| Share repurchases | $m | [5.4 d](/filings/0001410578-24-001769.md) | [3.6 d](/filings/0001104659-26-024659.md) | [5.8](/filings/0001410578-25-001089.md) | [6.5 d](/filings/0001410578-25-001607.md) | [0.1 d](/filings/0001104659-25-107609.md) | [2.7 d](/filings/0001104659-26-024659.md) | [10.2](/filings/0001104659-26-057039.md) | [9.8 d](/filings/0001104659-26-092625.md) | [10.0 d](/filings/0001104659-25-107609.md) | [14.4 d](/filings/0001104659-26-024659.md) | [16.9](/filings/0001104659-26-057039.md) | [7.8 d](/filings/0001104659-26-092625.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.3](/filings/0001410578-23-002223.md) | [12.2](/filings/0001410578-24-000572.md) | [12.0](/filings/0001410578-24-001169.md) | [11.9](/filings/0001410578-24-001769.md) | [11.8](/filings/0001410578-25-001089.md) | [11.6](/filings/0001410578-25-001607.md) | [11.7](/filings/0001104659-25-107609.md) | [11.6](/filings/0001104659-26-057039.md) | [11.5](/filings/0001104659-26-092625.md) | [11.3](/filings/0001104659-25-107609.md) | [11.0](/filings/0001104659-26-057039.md) | [10.9](/filings/0001104659-26-092625.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,897,507 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092625.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.